Loading…
Quoin Pharmaceuticals, Ltd. is projected to rise to $5.47 by 2027, a +23% move from its current price of $4.45. QNRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.28 | $4.46 | $4.64 | +0.12% |
| Aug 6 | $4.22 | $4.46 | $4.72 | +0.24% |
| Aug 7 | $4.17 | $4.47 | $4.78 | +0.36% |
| Aug 8 | $4.13 | $4.47 | $4.84 | +0.48% |
| Aug 9 | $4.10 | $4.48 | $4.89 | +0.60% |
| Aug 10 | $4.07 | $4.48 | $4.94 | +0.72% |
| Aug 11 | $4.04 | $4.49 | $4.99 | +0.84% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.04 | $4.49 | $4.99 | +0.84% |
| Week 2 | $3.90 | $4.53 | $5.25 | +1.69% |
| Week 3 | $3.80 | $4.56 | $5.48 | +2.54% |
| Week 4 | $3.73 | $4.60 | $5.68 | +3.41% |
| Week 5 | $3.67 | $4.64 | $5.87 | +4.28% |
| Week 6 | $3.62 | $4.68 | $6.06 | +5.15% |
| Week 7 | $3.57 | $4.72 | $6.23 | +6.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Quoin Pharmaceuticals, Ltd. is a late-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome; phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology.
Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Quoin Pharmaceuticals, Ltd. (QNRX) is the stock on focus. It trades around $4.21 per share and has a market cap of $8.46M, with a rank of 5177.
The stock operates in the Healthcare sector. Technical context shows sentiment is NEUTRAL, RSI14 at 40, and moving averages at SMA50 $4.91 and SMA200 $9.13.
Immediate support sits at $3.25 and resistance at $5.06, with a 30-day range from $2.93 to $6.06. Annualized volatility is 100%.
In the near term, the price outlook is neutral, while the longer-term forecast points to a path of higher average prices and rising ROI starting in 2027. In 2026 the average price is $4.21 with a 0 ROI and NEUTRAL sentiment.
A major floor 41.8% below — a decisive break under it would weaken the trend.
The nearest floor, 27.0% below — buyers have tended to step in here.
The nearest ceiling, 8.8% above — a clean break opens room to run.
A major ceiling 108.3% above — clearing it would confirm fresh momentum.
Key QNRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QNRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.32 | Buy | $4.36 | Buy |
| MA 10 | $4.31 | Buy | $4.34 | Buy |
| MA 20 | $4.38 | Buy | $4.37 | Buy |
| MA 50 | $4.50 | Sell | $4.73 | Sell |
| MA 100 | $5.57 | Sell | $5.73 | Sell |
| MA 200 | $8.83 | Sell | $8.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.88 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 33.54 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 5.70 | Buy |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.30 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 57.93 | Neutral |
| Momentum (10) | 0.21 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 4.35 | Buy |
| ADX (14) | 9.69 | Neutral |
| ATR (14) | 0.13 | Info |
The 30-day technical picture shows NEUTRAL sentiment with RSI(14) at 40. The stock sits below the SMA50 of $4.91 and well below the SMA200 of $9.13, suggesting limited upside pressure from the short-to-medium trend.
Near-term dynamics are tempered by a defined support at $3.25 and a resistance at $5.06. The latest 30-day range spans from $2.93 to $6.06, illustrating a broad trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.25 | $4.45 | $6.13 | 0% | Neutral | |
| $4.18 | $5.47 | $7.66 | +23% | Bullish | |
| $4.38 | $5.98 | $8.82 | +34% | Bullish | |
| $4.48 | $6.34 | $9.72 | +42% | Bullish | |
| $3.92 | $5.74 | $9.10 | +29% | Bullish | |
| $3.55 | $5.35 | $8.73 | +20% | Bullish | |
| $3.53 | $5.46 | $9.14 | +23% | Bullish | |
| $4.03 | $6.42 | $10.99 | +44% | Bullish | |
| $4.72 | $7.69 | $13.45 | +73% | Bullish | |
| $4.50 | $7.52 | $13.40 | +69% | Bullish | |
| $5.07 | $9.50 | $18.33 | +113% | Bullish | |
| $6.78 | $15.07 | $32.56 | +239% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.25 | $4.45 | $5.49 | +0.00% |
| September 2026 | $4.05 | $4.86 | $6.03 | +9.15% |
| October 2026 | $4.10 | $4.96 | $6.25 | +2.18% |
| November 2026 | $3.89 | $4.75 | $6.06 | -4.31% |
| December 2026 | $3.87 | $4.76 | $6.13 | +0.14% |
Click any year to see its month-by-month QNRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, QNRX is projected to trade between $3.25 and $6.13, averaging $4.45 — a potential gain of 0% from today's $4.45. Price action looks broadly range-bound.
Quoin Pharmaceuticals, Ltd.'s 2027 outlook centres on $5.47, within a $4.18 to $7.66 range. That is up +23% on the projected 2026 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, QNRX could reach as high as $8.82, with a base case around $5.98 and support toward $4.38 — roughly +34% from $4.45. Momentum favours further upside here.
Expect QNRX to range from $4.48 to $9.72 through 2029. The $6.34 average target implies a +42% move from current prices. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The QNRX price prediction for 2030 points to an average of $5.74 (low $3.92, high $9.10) — a potential gain of +29% on today's $4.45. Momentum favours further upside here.
In 2031, QNRX is projected to trade between $3.55 and $8.73, averaging $5.35 — a potential gain of +20% from today's $4.45. That is -7% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Quoin Pharmaceuticals, Ltd.'s 2032 outlook centres on $5.46, within a $3.53 to $9.14 range. That is up +2% on the projected 2031 average. That marks a +23% change versus current levels. Momentum favours further upside here.
By 2033, QNRX could reach as high as $10.99, with a base case around $6.42 and support toward $4.03 — roughly +44% from $4.45. Buyers look set to stay in control over this stretch.
Expect QNRX to range from $4.72 to $13.45 through 2034. The $7.69 average target implies a +73% move from current prices. That is up +20% on the projected 2033 average. Momentum favours further upside here.
The QNRX price prediction for 2035 points to an average of $7.52 (low $4.50, high $13.40) — a potential gain of +69% on today's $4.45. Buyers look set to stay in control over this stretch.
In 2040, QNRX is projected to trade between $5.07 and $18.33, averaging $9.50 — a potential gain of +113% from today's $4.45. That is up +26% on the projected 2035 average. Momentum favours further upside here.
Quoin Pharmaceuticals, Ltd.'s 2050 outlook centres on $15.07, within a $6.78 to $32.56 range. That is up +59% on the projected 2040 average. That marks a +239% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in QNRX today (≈ 224.719101 QNRX) could be worth
$3,385.6
+$2,385.6 (+239%) by 2050 · US Dollar
Based on the average projected QNRX price of $15.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QNRXwould be worth at today's price.
$1,000 invested in QNRX on Jul 31, 2025 (≈ 149.253736 QNRX) would be worth
$664.18
-$335.82 (-33.6%) today · 0.66× · US Dollar
Based on a QNRX entry price of $6.7 vs. today's $4.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.28 | $1,039.72 | +4.0% |
| 1 month ago | $4.71 | $944.8 | -5.5% |
| 3 months ago | $6.21 | $716.59 | -28.3% |
| 6 months ago | $8 | $556.25 | -44.4% |
| 1 year ago | $6.7 | $664.18 | -33.6% |
| All time (5.0y) ago | $86,730 | $0.05 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QNRX forecast.
Our base-case forecast reaches $8.90 around 2040.
Implied market cap at $8.90: $17.87M
The multi-year forecast lays out a gradual path for QNRX with notable upside later. The 2026 baseline shows min $3.25, avg $4.21, max $6.33 and ROI 0 with NEUTRAL sentiment. By 2027 the avg rises to $5.42 with min $3.94 and max $8.08 and ROI 28.8, a BULLISH signal. The 2028 forecast has avg $6.12, min $4.18, max $9.71 and ROI 45.3 (BULLISH).
In 2029, the avg is $6.84, min $4.43, max $11.39 and ROI 62.4 (BULLISH). The 2030 view shows avg $5.49, min $3.40, max $9.52 and ROI 30.4 (BULLISH). The 2031 outlook is avg $4.92, min $2.91, max $8.84 and ROI 16.9 (NEUTRAL).
The 2032 forecast has avg $5.48, min $3.11, max $10.14 and ROI 30.1 (BULLISH). For 2033 the avg is $5.99, min $3.26, max $11.40 and ROI 42.3 (BULLISH). The 2034 projection shows avg $7.65, min $4.01, max $14.93 and ROI 81.7 (BULLISH). In 2035 the avg is $7.91, min $3.99, max $15.80 and ROI 88 (BULLISH).
The 2040 forecast features avg $9.47, min $4.26, max $20.79 and ROI 125 (BULLISH). The long-range 2050 view shows avg $14.79, min $6.65, max $34.01 and ROI 251.2 (BULLISH). These numbers sketch a trajectory of higher average prices and large upside potential in the outer years, with bullish sentiment in most years and a brief neutral plateau around 2026-2031.
These are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows min $3.40, avg $5.49, max $9.52 with ROI 30.4 and sentiment BULLISH.
Forecasts show NEUTRAL in 2026, then BULLISH in 2027 through 2029 and again from 2032 onward, with max forecasts reaching $14.93 to $34.01 and ROI up to 251.2 by 2050.
Yes. The 2035 max is $15.80, and 2034 max is $14.93; the 2040 max is $20.79 and the 2050 max is $34.01.
Current price is $4.21 and market cap is $8.46M.
The 30-day range is between $2.93 and $6.06.
Quoin Pharmaceuticals, Ltd. Community Discussion
0Share your Quoin Pharmaceuticals, Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.